RENAISSANCE TECHNOLOGIES LLC

Position in PCVX — Vaxcyte, Inc.

CIK 1037389 NEW YORK, NY

Position in PCVX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,141,324

-$2,039,268 QoQ

Shares Held

19,634

-64.1% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#157

of 329 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. PCVX ranks #173 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,141,324	19,634	-64.1%	Shares	Sole	2026-08-13
2026-03-31	$3,180,592	54,734	-16.1%	Shares	Sole	2026-05-14
2025-12-31	$3,008,835	65,211	-19.0%	Shares	Sole	2026-02-12
2025-09-30	$2,898,781	80,477	-70.1%	Shares	Sole	2025-11-13
2025-06-30	$8,747,693	269,077	+37.1%	Shares	Sole	2025-08-13
2025-03-31	$7,411,419	196,277	+263.0%	Shares	Sole	2025-05-14
2024-12-31	$4,426,743	54,077	-74.9%	Shares	Sole	2025-02-13
2023-06-30	$10,760,921	215,477	-48.8%	Shares	Sole	2023-08-11
2023-03-31	$15,774,469	420,877	-19.4%	Shares	Sole	2023-05-12
2022-12-31	$25,028,797	521,977	+460.1%	Shares	Sole	2023-02-13
2022-09-30	$2,236,800	93,200	+28.4%	Shares	Sole	2022-11-14
2022-06-30	$1,579,776	72,600	+77.9%	Shares	Sole	2022-08-12
2022-03-31	$985,320	40,800	+213.8%	Shares	Sole	2022-05-13
2021-12-31	$309,270	13,000	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.